ProPhase Labs (PRPH) Current Deferred Revenue (2018 - 2026)
ProPhase Labs (PRPH) posted Current Deferred Revenue of $1.44 million for Q2 2026, up 1.4% from $1.42 million a year earlier and up 42.0% from the prior quarter.
ProPhase Labs (PRPH) Current Deferred Revenue (2018 - 2026) Analysis & Trends
At the end of FY2025, ProPhase Labs' Current Deferred Revenue came in at $1.5 million, down 11.6% from FY2024.
- Annual Current Deferred Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 54.8% (FY2020 to FY2025).
- In prior years, ProPhase Labs' Current Deferred Revenue was $1.7 million in FY2024 (-28.7%), $2.38 million in FY2023 (-4.7%), $2.5 million in FY2022 (+22.9%) and $2.03 million in FY2021.
- Quarterly Current Deferred Revenue has run from a low of $1.01 million in Q1 2026 to a high of $2.96 million in Q3 2022 over five years.
- On a year-over-year basis, Current Deferred Revenue increased in 1 of the last eight quarters, with an average decline of 18.6%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2021, with growth of 733.5%; the weakest was Q1 2024, with a decline of 42.6%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $1.01 million (Q1 2026), $1.5 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 2.45 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 2.84 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 2.43 Mn |
| Mar 31, 2022 | 2.25 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | 1.52 Mn |
ProPhase Labs Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();